Searching common pathogenetic factors between addictions and mental disorders: Dyshedonia and psychiatric comorbidity;Alla ricerca di fattori patogenetici comuni tra dipendenze e disturbi mentali: Disedonia e comorbidità psichiatrica

Italian Journal of Psychopathology

Volumn 12, Issue 1, 2006, Pages 72-84

  Manna, Vincenzo ^a,b  

^a Centro Salute Mentale   (Italy)

^b ASL Roma A   (Italy)

Author keywords

Addictions; Dyshedonia; Psychiatric comorbidity

Indexed keywords

EID: 36048937006     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Manna V, Di Rienzo AM, Caccianotti B, De Maio MSA. Neurobiologia delle farmaco-tossicodipendenze. Neurologia, Psichiatria, Scienze Umane 1997;17:367-79. (Pubitemid 27448846)
2. Wickler A, Pescor F. Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid - drinking behavior and relapse in morphine addicted rats. Psychopharmacology 1967;10:255-84.
3. Clouet D, Asghar K, Brown R. Mechanisms of cocaine abuse and toxicity. N.I.D.A. Research Monograph 88. Rockville: National Institute on Drug Abuse USA, 1988.
4. Mogenson GJ, Brudzynski SM, Wu M. From motivation to action: a review of dopaminergic regulation of limbic-nucleus accumbens-pedunculo-pontine nucleus circuitries involved in limbic-motor integration. In: Kalivas PW, Barnes CD, editors. Limbic Motor Circuits and neuropsychiatry. Boca Raton: CRC Press 1993, p. 193-236.
5. Schultz W. Predictive reward signal of dopamine neurons. Am J Physiol 1998;80:1-27. (Pubitemid 28326237)
6. Cabib S, Puglishi-Allegra S. Different effects of repeated stressful experiences on mesocortical and mesolimbic dopamine metabolism. Neuroscience 1996;73:375-80. (Pubitemid 26168799)
7. Cheer J, Kendall D, Marsden C. Cannabinoid receptors and reward in the rat: a conditioned place preference study. Arch Gen Psychiatry 2000;50:294-305.
8. Nisell M, Nomikos GC, Svensson TH. Systemic nicotine induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 1994;16:36-44. (Pubitemid 24013237)
9. Bunney E, Appel S, Brodie M. Electrophysiological effects of coca-ethylene, cocaine and ethanol on dopaminergic neurons of the ventral tegmental area. J Pharmacol Exp Ther 2001;297:696-710.
10. Cameron DL, Wessendorf MW, Williams JT. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 1997;77:155-66. (Pubitemid 27060315)
11. Seiden LS, Sabol KE, Ricuarte GA. Amphetamine: effects on catecholamine systems and behavior. Ann Rev Pharmacol Toxicol 1993;33:639-77. (Pubitemid 23116021)
12. Aine CJ. A conceptual overview and critique of functional neuro-imaging techniques in humans. I. MRE/fMRI and PET. Crit Rev Neurobiol 1995;9:229-309.
13. Volkow ND, Rosen B, Farde I. Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci USA 1997;94:2787-8. (Pubitemid 27157213)
14. Gatley SJ, Volkow ND. Addiction and imaging of the living human brain. Drug Alcohol Depend 1998;51:97-108. (Pubitemid 28353759)
15. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000;10:318-25. (Pubitemid 30159298)
16. Gorge MS, Anton RF, Bloomer C. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry 2001;58:345-52. (Pubitemid 32299531)
17. Bolla KI, Cadet JL, London ED. The neuropsychiatry of chronic cocaine abuse. J Neuro-Psychiatr Clin Neurosci 1998;10:280-9. (Pubitemid 28369623)
18. Markou A, Weiss F, Gold LH. Animal models of drug craving. Psychopharmacology 1993;112:163-82. (Pubitemid 23278275)
19. Shaham Y, Erb S, Stewart J. Stress-induced drug seeking to heroin and cocaine in rats: a review. Brain Res Rev 2000;33:13-33.
20. O'Brien C. Drug addiction and drug abuse. In: Hardman J, Limbird L, Gilman AG, editors. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill 2001, p. 621-42.
21. Vorel SR, Liu X, Hayes R. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 2001;292:1175-8. (Pubitemid 32440941)
22. Porrino LJ, Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: studies in animal models. Cereb Cortex 2000;10:326-33. (Pubitemid 30159299)
23. See R, Kruzich P, Grimm J. Dopamine, but not glutamate, receptor blockade in the dorsolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaineseeking behavior. Psychopharmacology 2001;156:301-10. (Pubitemid 32247191)
24. Thomas KL, Everitt BJ. Limbic-cortical-ventral striatal activation during retrieval of a discrete cocaine-associated stimulus: a cellular imaging study with gamma-protein-kinase- C expression. J Neurosci 2001;21:2526-35. (Pubitemid 32240549)
25. Franklin TR, Druhan J P. Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocaine-paired environment. Eur J Neurosci 2000;12:2097-106. (Pubitemid 30348847)
26. Ciccocioppo R, Sanna PP, Weiss F. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D1 antagonists. Proc Natl Acad Sci USA 2001;98:1976-81. (Pubitemid 32165608)
27. McFarland K, Kalivas PW. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 2001;21:8655-63. (Pubitemid 33051463)
28. Grimm J, See R. Dissociation of primary and secondary reward relevant limbic nuclei in an animal model of relapse. Neuropsychopharmacology 2000;22:473-9. (Pubitemid 30145615)
29. Kalivas PW, McFarland K, See R. Drug dependences. In: Tasman A, Kay J, Lieberman JA, editors. Psychiatry. New York: John Wiley & Sons Ltd 2003.
30. Nestler E. Molecular basis of long-term plasticity underlying addiction. Nat Rev 2001;2:119-28. (Pubitemid 33673366)
31. Kalivas PW. The development and expression of behavioral sensitization: temporal profile of changes in gene expression. In: Moldanado R, editor. Molecular biology of Drug Addiction. Totowa, NJ: Humana Press 2002.
32. WHO Report. Neuroscience of Psychoactive Substance Use and Dependence. Geneva 2004.
33. Cheng LS, Swan GE, Carmelli D. A genetic analysis of smoking behavior in family members of older adult males. Addiction 2000;95:427-35. (Pubitemid 30167636)
34. McGue M, Elkins I, Iacono WG. Genetic and environmental influences on adolescent substance use and abuse. Am J Med Genet 2000;96:671-7.
35. Bergen AW. A genome-wide search for loci contributing to smoking and alcohol dependence. Genet Epidemiol 1999;17(Suppl 1):S55-60.
36. Straub RE. Susceptability genes for nicotine dependence: a genome scan and follow-up in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiatry 1999;4:129-44. (Pubitemid 29163976)
37. Duggirala R, Almasy L, Blangero J. Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. Genet Epidemiol 1999;17(Suppl 1):S139-44.
38. Carmelli D. Genetic influence on smoking: a study of male twins. N Engl J Med 1992;327:829-33.
39. Long JC. Evidence for the genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome wide-scan in an American Indian population. Am J Med Gen 1998;81:216-22.
40. Lappaleinen L. Linkage of antisocial alcoholism to the serotonin 5 HT1B receptor gene in two populations. Arch Gen Psychiatry 1998;55:989-94.
41. Agarwal DP. Genetic polymorphisms of alcohol metabolizing enzymes. Pathol Biol 2001;49:703-9. (Pubitemid 33091863)
42. Li TK. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. J Stud Alcohol 2000;61:5-12.
43. Ramchandani VA, Bosron WF, Li TK. Research advances in ethanol metabolism. Pathol Biol 2001;49:676-82. (Pubitemid 33091859)
44. Tsuang MT. The Harvard Twin Study of Substance Abuse: what we have learned. Harv Rev Psychiatry 2001;9:267-79. (Pubitemid 33010369)
45. Swan GE, Carmelli D, Cardon LR. The consumption of tobacco, alcohol and coffee in Caucasian male twins: a multivariate genetic analysis. J Subst Abuse 1996;8:19-31. (Pubitemid 26233199)
46. Swan GE, Carmelli D, Cardon LR. Heavy consumption of cigarettes, alcohol and coffee in male twins. J Stud Alcohol 1997;58:182-90. (Pubitemid 27084085)
47. Merikangas KR. Familial transmission of substance use disorders. Arch Gen Psychiatry 1998;55:973-9. (Pubitemid 28506838)
48. Beirut LJ. Familial transmission of substance dependence: alcohol, marijuana, cocaine and habitual smoking: a report from the Collaborative Study on Genetics of Alcoholism. Arch Gen Psychiatry 1998;55:982-8.
49. Swan GE. Implications of genetic epidemiology for the prevention of tobacco use. Nicotine and Tobacco Research 2001;1(Suppl 1):S49-56.
50. Ribot J. La psychologie des sentiments. Paris: Felix Alcan 1896.
51. Bleuler E. Dementia praecox oder Gruppe der Schizophrenien. Leipzig: Verlag von Franz Deulicke 1911.
52. Kraepelin E. Dementia praecox and paraphrenia. Edinburgh: Livingstone 1919 (original work published 1913).
53. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition (DSM-IIIR). Washington DC: American Psychiatric Press 1987.
54. Ettenberg A. Anhedonia. In: Costello CG, editor. Symptoms of schizophrenia. New York: Wiley 1993, p. 121-144.
55. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (DSM IV). Washington DC: American Psychiatric Press 1994.
56. Willner P, Klimek V, Golembiowska K, Muscat R. Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 1991;19:79-84.
57. Manna V, Daniele MT, Pinto M. Disedonia. Ruolo della disregolazione omeostatica edonica nelle dipendenze patologiche da sostanze ed in altri disturbi psicopatologici. Giorn Ital Psicopat 2003;9:71-92. (Pubitemid 36313947)
58. Koob GF, Le Moal M. Drug Abuse: Hedonic Homeostatic Dysregulation. Science 1997;278:52-8. (Pubitemid 27446270)
59. Crow TJ. Catecholamine-containing neurones and electrical self-stimulation: a review of some data. Psychol Med 1972;2:414-21.
60. German DC, Bowden DM. Catecholamine systems as neural substrate of intracranial self-stimulation: a hypothesis. Brain Res 1974;73:381-419.
61. Lippa AS, Antleman S, Fisher A, Canfield D. Neurochemical mediation of "reward": a significant role for dopamine. Pharmacol Biochem Behav 1973;1:25-8.
62. Wise RA. The anhedonia hypothesis: mark III. Behav Brain Sci 1985;8:178-86.
63. Wise RA, Spindler J, de Witt H, Gerberg GJ. Neuroleptic induced "anhedonia" in rats: pimozide blocks "reward"quality of food. Science 1978;201:262-4. (Pubitemid 8396751)
64. Wise RA. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 1982;5:39-87.
65. Xenakis S, Sclafani A. The dopaminergic mediation of a sweet "reward" in normal and VMH hyperphagic rats. Pharmacol Biochem Behav 1982;16:293-302. (Pubitemid 12138149)
66. Di Chiara G. The role of dopamine in drug abuse viewed from the prospective of its role in motivation. Drug and Alcohol Dependence 1995;38:95-137.
67. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 1998;12:54-67. (Pubitemid 28143000)
68. Welch CC, Kim EM, Grace MK, Billington CJ, Levin AS. Palatability induced hyperphagia increase hypothalamic dynorphin peptide and mRNA levels. Brain Res 1996;721:126-31. (Pubitemid 26179845)
69. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Bio-Behav Rev 1996;20:1-25. (Pubitemid 126682107)
70. Simon H, Le Moal M, Calas A. Efferents and afferents of the ventral tegmental A10 region studied after local injection of 3H-leucine and horse radish peroxidase. Brain Res 1979;178:17-40. (Pubitemid 10241289)
71. Fritze J, Beckman H. The cholinergic agonist RS86: a pharmacopsychological study. Neuropsychobiology 1988;19:35-9.
72. Sano M. Basal ganglia diseases and depression. Neuropsychol Behav Med 1991;4:41-8.
73. Ebmeir K, Ebert D. Imaging functional change and dopaminergic activity in depression. In: Beniner RJ, Palomo T, Archer T, editors. Dopamine disease state. Madrid: Fundacion Cerebro y Mente 1996, p. 511-22.
74. Frecska E, Arato M, Banki CM, Mohar K, Perenyi A, Bagdy G, et al. Prolactin response to fentanyl in depression. Biol Psychiatry 1989;25:692-6. (Pubitemid 19101985)
75. Papp M, Lappas S, Muscat R, Willner P. Attenuation of place preference conditioning, but not place avversion conditioning by chronic mild stress. Ital J Psychopathol 1992;6:352-6.
76. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning or incentive salience? Brain Res Rev 1998:309-69. (Pubitemid 29012677)
77. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, et al. Haloperidol antagonism of cue-elicited cocaine craving. Lancet 1996;347:504-8. (Pubitemid 26061611)
78. Brauer LH, Goudie AJ, de Wit H. Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology (Berlin) 1997;130:2-13. (Pubitemid 27107780)
79. Modell JG, Mountz JM, Glaser FB, Lee JY. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol Clini Exp Res 1993;17:234-40. (Pubitemid 23135424)
80. Edwards G, Arif A, Hodgson R. Nomenclature and classification of drug- and alcohol-related problems: a WHO memorandum. Bull World Health Organ 1981;59:225-42. (Pubitemid 11035754)
81. Regier DA, Farmer ME, Rae BS. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-8.
82. Schutckit MA. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiat 1985;42:1043-9.
83. Kessler RC. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Ortho-Psychiatry 1996;66:17-31. (Pubitemid 26031236)
84. Glassman AH. Smoking, smoking cessation and major depression. JAMA 1990;264:1546-9.
85. Breslau N. Psychiatrici Comorbidity of smoking and nicotine dependence. Behavior Genetics 1995;25:95-101.
86. Hughes JR. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986;143:993-7. (Pubitemid 16073948)
87. Robins LN, Regier DA. Psychiatric disorders in America: the Epidemiologic Catchment Area Study. New York: The Free Press 1991.
88. Kessler RC, McGonagle KA, Shanyang Z. Lifetime and 12- month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. (Pubitemid 24028993)
89. Le Duc PA, Mittleman G. Schizophrenia and psychostimulant abuse: a review and reanalysis of clinical evidence. Psycopharmacology 1995;121:407-27.
90. Warner LA, Kessler RC, Huges M. Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:219-29.
91. Manna V, Ruggiero S. Dipendenze patologiche da sostanze: comorbidità psichiatrica o continuum psicopatologico? Rivista di Psichiatria 2001;36:1-14.
92. Maremmani I, Canoniero S, Zolesi O. Forme cliniche del craving e farmaci anticraving. Itaca 1999;7:20-39.
93. Manna V, Mescia G, Fettone MC, Giordano MA. Ouroboros: il serpente alchemico. Verso l'integrazione tra psicoterapia e farmacoterapia nel trattamento dei disturbi mentali correlati all'abuso di sostanze. Giorn Ital Psicopat 1998;2:209-16.
94. Manna V. www.salus.it/medicinadelledipendenze/index.htlm. 2001
95. Manna V. Dipendenze patologiche da sostanze e depressione: verso il trattamento integrato multi-modale. Minerva Psichiatrica 2002;43:29-35.
96. Manna V, Fettone CM. Alcol-dipendenza, abuso di sostanze e craving: considerazioni cliniche e proposta di un trattamento integrato multimodale. Bollettino Italiano delle Farmacodipendenze e l'Alcolismo 2001;1:50-61.
97. Shayegan DK, Stahl SM. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. CNS Spectr 2004;9(Suppl 11):6-14. (Pubitemid 39473434)
98. Manna V, Daniele MT, Pinto M. Oltre i limiti della personalità limite. Ruolo dell'impulsività nel disturbo borderline di personalità. Giorn Ital Psicopat 2005;11:76-86.